Serum levels of vascular endothelial growth factor-A and -B in patients with advanced non-small cell lung cancer treated with pembrolizumab: prognostic and predictive value
Year: 2024
Type: conference-abstract
Source: Lung Cancer
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4404097121
